Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.35 |
| ▸ | PPARG | P37231 | 5/20 | 0.35 |
| ▸ | RARG | P13631 | 4/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12424227 | 0.93 | — | — | |
| SCHEMBL12424228 | 0.92 | RXRA (0.33) | RXRAPPARGRARGRARARARB | |
| SCHEMBL13356449 | 0.92 | RXRA (0.36) | RXRAPPARGRARGRARARARB | |
| SCHEMBL29353638 | 0.92 | RXRA (0.37) | RXRAPPARGRARGRARARARB | |
| SCHEMBL237192 | 0.92 | RXRA (0.37) | RXRAPPARGRARGRARARARB | |
| SCHEMBL29464292 | 0.92 | RXRA (0.37) | RXRAPPARGRARGRARARARB | |
| SCHEMBL13356450 | 0.90 | RXRA (0.35) | RXRAPPARGRARGRARARARB | |
| SCHEMBL13356407 | 0.90 | RXRA (0.36) | RXRAPPARGRARGRARARARB | |
| SCHEMBL14125277 | 0.90 | RXRA (0.36) | RXRAPPARGRARGRARARARB | |
| SCHEMBL4411077 | 0.88 | CYP1A2 (0.39) | RXRAPPARGRARGRARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977418-B2 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977418-B2 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-12 | — | — | US | disclosed |
| EP-2022819-B1 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | SUMITOMO CHEMICAL CO (JP) | 2010-05-12 | — | — | EP | disclosed |
| US-20090043027-A1 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-12 | — | — | US | disclosed |
| US-20090043027-A1 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2009-02-12 | — | — | US | disclosed |
| EP-2022819-A1 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | Sumitomo Chemical Company, Limited (JP) | 2009-02-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090043027-A1 | Bisphenol monoester-based stabilizer composition, thermoplastic polymer composition and method of manufacturing the same, thermoplastic polymer molded product, and method of stabilizing thermoplastic polymer | PCBP1, MMS19, PUF60 | RXRA 647/4885PPARG 350/4885RARG 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.